FDA to Remove 12 Popular Peptides from the Category 2 Do Not Compound List Frier Levitt FDA Peptide Update 2026: Removal from Do Not Compound List and What It Means for Pharmacies People are turning themselves into lab rats': the injectable peptides craze sweeping the US Well actually The Guardian FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.'s Wishes The New York Times Valor Compounding Pharmacy Inc. Berkeley, CA. Untitled Letter issued 03 23 2023 August 11, 2025: The FDA voices concern about sites that supply compounding ingredients Partnership for Safe Medicines FDA Moves on Peptides: What Compounding Pharmacies Need to Know